China BioPharma Ltd.
About China BioPharma Ltd.
China Biopharma Inc. (CBI) is a provider of pharmaceutical products with its focus mainly on the introduction and marketing of human vaccines and other pharmaceutical products. It has established its distribution and development platform in China and as a result of its acquisition of interest in its majority owned subsidiary, Hainan CITIC Bio-pharmaceutical Development Co., Ltd. (HCBD) and, as a result of its joint venture with Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd. (Zhejiang Tianyuan). It has two operational segments. One segment, consisting of CBL and its subsidiaries provides bio-pharmaceutical products. The other segment, which consists of China Quantum Communication Limited (CQCL) and its subsidiary, was engaged in the business of providing telecommunications services and developing related technology. However, following its re-positioning of its business focus from telecommunications to pharmaceutical operations, CQCL ceased carrying on any daily business activities.11 articles about China BioPharma Ltd.
-
China BioPharma Ltd. Eyes Buyout of Tianyuan Biotech JV; Move Away from Vaccines
11/21/2007
-
China Biopharma Inc. Reports Progress on Topical Antiviral
10/19/2007
-
China BioPharma Ltd. Completes Funding To Its Joint Venture Subsidiary
1/16/2007
-
China BioPharma Ltd. Receives Order To Export Flu Vaccine To Macedonia
9/7/2006
-
China BioPharma Ltd. Manufacturing Partner Receives SFDA Approval To Deliver Flu Vaccine For The First Batch Release Of The 2006-2007 Season
8/31/2006
-
China BioPharma Ltd. Retains The Global Consulting Group As Investor Relations Counsel
8/15/2006
-
China BioPharma Ltd. Signs Letter Of Intent To Acquire Hainan CITIC Biopharmaceutical, China's Largest Vaccine Distributor
6/21/2006
-
China BioPharma Ltd. Receives Approval From PRC Regulatory Agency
5/31/2006
-
China BioPharma Ltd. Appoints Mr. Shenqian Nie, The CEO Of CITIC Pharmaceutical To The Independent Board Of Directors
5/10/2006
-
China BioPharma Ltd. Appoints Dr. Yimin Yu, Current Chairman Of HYTE Research To Advisory Board
4/20/2006
-
Techedge Inc. Signs Definitive Agreement To Acquire China BioPharma Ltd.
4/10/2006